Juvenile Myelomonocytic Leukemia

general

A clonal myeloid disorder of childhood previously classified as myelodysplastic/myeloproliferative neoplasm. It is characterized by the presence of monocytic proliferation in peripheral blood, less than 20% blasts in bone marrow and peripheral blood, splenomegaly, and the absence of BCR-ABL1 fusion. Almost all patients carry mutations of the RAS pathway.

65

Centers

84

Active Trials

$6M

Cancer Funding

Specific Cancer Types(2)

Top Centers for Juvenile Myelomonocytic Leukemia(65)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
81.7
2
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
High-Volume Research Center
71.6
3
NCI Comprehensive
High-Volume Research Center
70.9
4
NCI Comprehensive
Active Research Program
63.8
5
NCI Comprehensive
Active Research Program
63.6
6
NCI Comprehensive
Active Research Program
63.6
7
NCI Comprehensive
Active Research Program
63.6
8
NCI Comprehensive
Active Research Program
63.6
9
NCI Comprehensive
Active Research Program
63.6
10
NCI Comprehensive
Active Research Program
63.6
11
NCI Comprehensive
Active Research Program
63.6
12
NCI Clinical
Active Research Program
63.6
13
NCI Comprehensive
Active Research Program
63.6
14
Active Research Program
63.6
15
NCI Comprehensive
Active Research Program
63.6
16
Active Research Program
63.6
17
Active Research Program
63.6
18
Active Research Program
63.6
1963.6
20
Active Research Program
63.6
21
Active Research Program
63.6
22
Active Research Program
63.6
23
Active Research Program
63.6
24
NCI Comprehensive
Active Research Program
51.0
25
NCI Comprehensive
Active Research Program
50.0
26
NCI Comprehensive
Active Research Program
49.4
27
NCI Comprehensive
Active Research Program
47.3
28
NCI Comprehensive
Active Research Program
47.3
29
NCI Comprehensive
Active Research Program
47.3
30
NCI Comprehensive
Active Research Program
47.3
31
NCI Comprehensive
Active Research Program
47.3
32
NCI Comprehensive
Active Research Program
47.3
33
NCI Comprehensive
Active Research Program
47.3
3447.3
35
NCI Comprehensive
Active Research Program
47.3
36
NCI Clinical
Active Research Program
47.3
37
NCI Comprehensive
Active Research Program
47.3
38
Active Research Program
47.3
39
NCI Clinical
Active Research Program
47.3
40
NCI Comprehensive
Active Research Program
47.3
41
NCI Comprehensive
Active Research Program
47.3
42
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
47.3
43
NCI Clinical
Active Research Program
47.3
44
NCI Comprehensive
Active Research Program
47.3
45
Active Research Program
47.3
46
Active Research Program
47.3
47
Active Research Program
47.3
48
Active Research Program
47.3
4947.3
50
Active Research Program
47.3
51
BC CancerVancouver, BC
Active Research Program
47.3
52
Active Research Program
47.3
53
NCI Comprehensive
32.5
54
NCI Comprehensive
32.5
55
NCI Comprehensive
32.5
56
NCI Comprehensive
32.5
5732.5
58
NCI Comprehensive
32.5
59
NCI Comprehensive
32.5
60
Cedars-Sinai CancerLos Angeles, CA
32.5
61
NCI Comprehensive
32.5
62
NCI Comprehensive
32.5
6332.5
6432.5
6532.5

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →